Purchase Order 36C77026P0040
Award Date 1/26/26
Potential Completion Date 3/5/26
Potential Value $318K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
7
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 22, 2025, for Candesartan Cilexetil 16 mg tablets (90 count) with a ceiling value of $1,727.22. This competitive, firm fixed-price award carries an ultimate completion date of October 23, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on August 28, 2025, from the Defense Logistics Agency's Medical Supply Chain for Candesartan Cilexetil 8 mg tablets (90-count). The contract is valued at $2,152.03 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. This non-set-aside award was competitively awarded and represents a child contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp was awarded a $2,385.30 delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Candesartan Cilexetil 16 mg tablets (90-count supply) by the Defense Logistics Agency on September 9, 2025, with a ceiling value of $3,517.92 under firm fixed pricing. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with a ceiling value of $1,143.34. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,178.51, is for the delivery of Candesartan Cilexetil 32 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price arrangement with a completion date of June 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.39 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 4 mg tablets in 90-count packages. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Valsartan-HCTZ 320-25 mg tablets in quantities of 90 per container. This competitively awarded, firm fixed-price delivery order was executed on September 18, 2025, with a ceiling value of $16,112.58 and an ultimate completion date of September 19, 2025. The contract carries no set-aside designation, indicating open competition among...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order against an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, provides for the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to support military treatment...